Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedAug 17, 2024
DataAggregated Company Financials
Companies4
  • 7D-3.3%
  • 3M-10.0%
  • 1Y-35.2%
  • YTD-28.3%

Over the last 7 days, the Life Sciences industry has dropped 2.5%, driven by Gerresheimer declining 0.4%. Meanwhile, Evotec actually outperformed within the industry, gaining 9.0% in the last week. Overall the industry is down 38% in 12 months. As for the next few years, earnings are expected to grow by 29% per annum.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 17 Aug 2024€23.9b€7.0b€157.1m35.1x152.3x3.4x
Mon, 15 Jul 2024€24.7b€7.0b€307.9m37.1x80.3x3.5x
Wed, 12 Jun 2024€25.0b€7.0b€333.3m31.6x74.9x3.6x
Fri, 10 May 2024€28.2b€7.0b€340.1m35.3x82.9x4x
Sun, 07 Apr 2024€32.8b€7.1b€384.5m38x85.4x4.6x
Tue, 05 Mar 2024€33.5b€7.1b€384.5m37.7x87.2x4.7x
Thu, 01 Feb 2024€32.2b€7.3b€516.3m35.7x62.4x4.4x
Sat, 30 Dec 2023€32.5b€7.3b€507.1m35.5x64.2x4.5x
Mon, 27 Nov 2023€28.3b€7.3b€507.1m30.1x55.7x3.9x
Wed, 25 Oct 2023€20.9b€6.4b€356.1m38.8x58.8x3.3x
Fri, 22 Sep 2023€26.8b€6.6b€498.1m39x53.7x4.1x
Sun, 20 Aug 2023€29.5b€6.6b€425.8m43.3x69.2x4.5x
Tue, 18 Jul 2023€26.8b€6.8b€496.6m35.7x53.9x4x
Thu, 15 Jun 2023€28.8b€6.7b€487.3m39.9x59.1x4.3x
Sat, 13 May 2023€28.1b€6.7b€483.0m38.7x58.2x4.2x
Mon, 10 Apr 2023€30.8b€6.8b€595.6m34.1x51.7x4.5x
Wed, 08 Mar 2023€30.7b€6.7b€594.3m34.4x51.7x4.6x
Fri, 03 Feb 2023€33.4b€6.5b€447.4m41.2x74.6x5.2x
Sun, 01 Jan 2023€28.8b€6.5b€447.4m34.4x64.3x4.5x
Tue, 29 Nov 2022€28.6b€6.5b€447.4m35.1x63.9x4.4x
Thu, 27 Oct 2022€27.8b€6.4b€629.0m45.9x44.3x4.3x
Sat, 24 Sep 2022€4.6b€2.3b€84.0m979.2x55x2x
Mon, 22 Aug 2022€6.4b€2.3b€84.0m1428.3x76.1x2.8x
Wed, 20 Jul 2022€6.1b€2.3b€171.9m35x35.6x2.7x
Fri, 17 Jun 2022€6.3b€2.2b€173.3m35.6x36.2x2.8x
Sun, 15 May 2022€6.5b€2.2b€173.3m36.5x37.2x2.9x
Tue, 12 Apr 2022€7.0b€2.1b€331.2m22.5x21x3.3x
Thu, 10 Mar 2022€6.7b€2.1b€342.9m18.5x19.5x3.2x
Sat, 05 Feb 2022€8.1b€2.0b€345.6m21.8x23.5x4x
Mon, 03 Jan 2022€10.4b€2.0b€345.9m30.1x29.9x5.1x
Wed, 01 Dec 2021€10.1b€2.0b€345.8m29.4x29.2x5x
Fri, 29 Oct 2021€9.7b€2.0b€209.8m29.2x46.1x4.8x
Sun, 26 Sep 2021€10.0b€2.0b€222.7m28.9x45x5.1x
Tue, 24 Aug 2021€10.2b€2.0b€222.8m30.3x45.7x5.1x
Price to Earnings Ratio

45.7x


Total Market Cap: €10.2bTotal Earnings: €222.8mTotal Revenue: €2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 55x202220232024
Current Industry PE
  • Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 100x which is higher than its 3-year average PE of 54.8x.
  • The 3-year average PS ratio of 4.1x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 2.1% per year over the last three years.
  • Revenues for these companies have grown 53% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market2.81%
Healthcare2.22%
Life Sciences-3.31%
Clinical Research and Equipment-3.31%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EVT Evotec€5.804.5%
+€44.3m
-71.5%PS1.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.